国药控股股份有限公司（股票代码：01099）于2026年4月9日披露2026年3月股份变动月报。根据公告，截至2026年3月31日，公司注册股本数额及已发行股份总数均保持稳定，未有新增发行、购回或注销活动。
注册股本方面，公司H股注册股本为1,341,810,740股，内资股注册股本为1,778,845,451股，合计3,120,656,191股。报告期内，H股与内资股的数量均未发生变化。已发行股份方面，H股和内资股的已发行数量与上月底持平，库藏股数目为零。
公司在报告期内未披露任何股份期权或股权激励计划的变动，也无购回或注销股份的记录。截至本月末，公司总体股本状况保持稳定。公司确认遵守香港联交所《上市规则》的相关要求。公告由公司秘书吴壹建签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.